Cargando…

Evaluation of Glutaminase Expression in Prostate Adenocarcinoma and Correlation with Clinicopathologic Parameters

SIMPLE SUMMARY: High expression levels of glutaminase (GLS1) are reported for several cancers, and correlate with parameters of disease status. GLS1, the rate-limiting enzyme in the glutamine pathway, is involved in DNA/RNA and amino acid synthesis and contributes to other pathways (e.g., TCA cycle)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Myint, Zin W., Sun, Ramon C., Hensley, Patrick J., James, Andrew C., Wang, Peng, Strup, Stephen E., McDonald, Robert J., Yan, Donglin, St. Clair, William H., Allison, Derek B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124252/ https://www.ncbi.nlm.nih.gov/pubmed/33947068 http://dx.doi.org/10.3390/cancers13092157

Ejemplares similares

Association of CD47 Expression with Clinicopathologic Characteristics and Survival Outcomes in Muscle Invasive Bladder Cancer
por: Myint, Zin W., et al.
Publicado: (2023)

A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer
por: Myint, Zin W., et al.
Publicado: (2023)

A single arm phase II study of bone-targeted Sn-117 m-DTPA in symptomatic castration-resistant prostate cancer with skeletal metastases
por: Myint, Zin W., et al.
Publicado: (2022)

A Case Report of Metastatic Castration-Resistant Prostate Cancer Harboring a PTEN Loss
por: Myint, Zin W., et al.
Publicado: (2021)

Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
por: Jacob, Aasems, et al.
Publicado: (2021)

Prostate Adenocarcinoma with Brain Metastasis: A Surveillance, Epidemiology, and End Results Database Analysis 2010–2015
por: Myint, Zin W., et al.
Publicado: (2021)

The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy
por: Lukey, Michael J., et al.
Publicado: (2016)

Clinicopathological and immunological profiles of prostate adenocarcinoma and neuroendocrine prostate cancer
por: Huang, Gang, et al.
Publicado: (2022)

Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015)

Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer
por: Udupa, Sunag, et al.
Publicado: (2019)

Prostate SBRT using O‐Ring Halcyon Linac — Plan quality, delivery efficiency, and accuracy
por: Pokhrel, Damodar, et al.
Publicado: (2020)

Dendrimer-conjugated glutaminase inhibitor selectively targets microglial glutaminase in a mouse model of Rett syndrome
por: Khoury, Elizabeth Smith, et al.
Publicado: (2020)

Q-ing tumor glutaminase therapy
por: Stine, Zachary E., et al.
Publicado: (2015)

Governing glutaminolysis by regulation of glutaminase succinylation
por: Ma, Qingxia, et al.
Publicado: (2021)

The Role of Glutamine and Glutaminase in Pulmonary Hypertension
por: Wang, Shang, et al.
Publicado: (2022)

Targeting glutaminase to starve lymphoma cells
por: Dumontet, Charles
Publicado: (2022)

Targeting hepatic glutaminase activity to ameliorate hyperglycemia
por: Miller, Russell A., et al.
Publicado: (2018)

Expression of Survivin and Cortactin in Colorectal Adenocarcinoma: Association with Clinicopathological Parameters
por: Lee, Ying-Yu, et al.
Publicado: (2009)

A second case of glutaminase hyperactivity: Expanding the phenotype with epilepsy
por: Rumping, Lynne, et al.
Publicado: (2023)

Clinicopathologic features of incidental prostatic adenocarcinoma in radical cystoprostatectomy specimens
por: Aytac, Berna, et al.
Publicado: (2011)

ERG Immunohistochemistry and Clinicopathologic Characteristics in Korean Prostate Adenocarcinoma Patients
por: Suh, Ja Hee, et al.
Publicado: (2012)

ERG oncoprotein expression in prostatic acinar adenocarcinoma; clinicopathologic significance
por: Hashmi, Atif Ali, et al.
Publicado: (2019)

Prevalence of HER2 Expression and Its Correlation with Clinicopathological Parameters in Gastric or Gastroesophageal Junction Adenocarcinoma in North-East Indian Population
por: Roy, Partha S, et al.
Publicado: (2019)

Evaluation of Fall and Fracture Risk Among Men With Prostate Cancer Treated With Androgen Receptor Inhibitors: A Systematic Review and Meta-analysis
por: Myint, Zin W., et al.
Publicado: (2020)

Metabolic modulation of neurogenesis: Role of glutaminase-2
por: Salomoni, Paolo
Publicado: (2014)

Safety assessment of glutaminase from Aspergillus niger
por: Vo, Trung Duc, et al.
Publicado: (2020)

Glutaminase inhibition in renal cell carcinoma therapy
por: Raczka, Aleksandra M., et al.
Publicado: (2019)

Identification and characterization of a novel glutaminase inhibitor
por: Cederkvist, Henning, et al.
Publicado: (2021)

Expression of Cortactin and Focal Adhesion Kinase in Colorectal Adenocarcinoma: Correlation with Clinicopathologic Parameters and Their Prognostic Implication
por: Kim, Yo Na, et al.
Publicado: (2012)

High Levels of Glutaminase II Pathway Enzymes in Normal and Cancerous Prostate Suggest a Role in ‘Glutamine Addiction’
por: Dorai, Thambi, et al.
Publicado: (2019)

Study the Expression of CD10 in Prostate Carcinoma and its Correlation with Various Clinicopathological Parameters
por: Singh, Lalit, et al.
Publicado: (2019)

Structural basis for exploring the allosteric inhibition of human kidney type glutaminase
por: Ramachandran, Sarath, et al.
Publicado: (2016)

Aspirin reprogrammes colorectal cancer cell metabolism and sensitises to glutaminase inhibition
por: Holt, Amy K., et al.
Publicado: (2023)

Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcoma
por: Ren, L., et al.
Publicado: (2020)

Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: Clinical efficacy and correlative analyses
por: Konopleva, Marina, et al.
Publicado: (2023)

Low glutaminase and glycolysis correlate with a high transdifferentiation efficiency in mouse cortex
por: Li, Yuan, et al.
Publicado: (2023)

Metabolic Heterogeneity, Plasticity, and Adaptation to “Glutamine Addiction” in Cancer Cells: The Role of Glutaminase and the GTωA [Glutamine Transaminase—ω-Amidase (Glutaminase II)] Pathway
por: Cooper, Arthur J. L., et al.
Publicado: (2023)

Correlation of pulmonary venous circulating tumor cells with clinicopathological parameters in patients with early-stage lung adenocarcinoma
por: Xu, Shi-Bin, et al.
Publicado: (2019)

Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine Exploitation
por: Caiola, Elisa, et al.
Publicado: (2020)

Effect of glutaminase inhibition on cancer-induced bone pain
por: Fazzari, Jennifer, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i975k8gp34rkkv3mvjkc9t3udr